| Literature DB >> 15755469 |
Panagiotis T Vlagopoulos1, Mark J Sarnak.
Abstract
Chronic kidney disease (CKD) is public health problem, with as many as 20 million individuals affected in the United States. Patients with CKD should be considered in the highest-risk group for development of cardiovascular disease (CVD), and aggressive treatment of traditional and nontraditional risk factors should be instituted. Additional randomized controlled trials are urgently needed to evaluate potential treatments in this population. This article focuses attention on the major modifiable cardiovascular risk factors in CKD.Entities:
Mesh：
Year: 2005 PMID： 15755469 DOI： 10.1016/j.mcna.2004.11.003
Source DB: PubMed Journal: Med Clin North Am ISSN： 0025-7125 Impact factor: 5.456